Kit Simpson to Spiro Compounds
This is a "connection" page, showing publications Kit Simpson has written about Spiro Compounds.
Connection Strength
0.963
-
Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain. J Comp Eff Res. 2021 10; 10(15):1107-1119.
Score: 0.763
-
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events. Expert Rev Pharmacoecon Outcomes Res. 2022 Jun; 22(4):671-681.
Score: 0.200